ProfileGDS5822 / ILMN_1236165
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 33% 24% 25% 22% 43% 32% 20% 47% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.133
GSM1276600PDAC Late Ablation Control 215.724
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 112.425
GSM1276603PDAC Late Ablation 212.622
GSM1276604PDAC Late Ablation 320.843
GSM1303940PDAC Late Ablation_anti-CTLA4 11632
GSM1303941PDAC Late Ablation_anti-CTLA4 210.920
GSM1303942PDAC Late Ablation_anti-CTLA4 323.647